|
|
|
1,001-5,000 employees
View all
|
|
medical device
|
|
7555 Innovation Way,Mason,Ohio,US
|
|
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 150,000 implanted to date. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.
|
AtriCure, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
89.66%
|
The widely used AtriCure, Inc. email format is {f}{last} (e.g. [email protected]) with 89.66% adoption across the company.
To contact AtriCure, Inc. customer service number in your country click here to find.
David Drachman is the CEO of AtriCure, Inc.. To contact David Drachman email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.